ArticleBMC medicine2022

Intracranial efficacy of alectinib in ALK-positive NSCLC patients with CNS metastases-a multicenter retrospective study.

Zihua Zou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.